Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
about
Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement.Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest.Recombinant factor VII is associated with worse survival in complex cardiac surgical patientsCombination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery programAntegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: does it matter? A propensity-matched analysis.Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery.The utility of the aortic dissection team: outcomes and insights after a decade of experience.Predictors of electrocerebral inactivity with deep hypothermia.Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery.Managing the Rising Costs and High Drug Expenditures in Critical Care Pharmacy Practice.Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding.Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report).Massive bleeding in cardiac surgery. Definitions, predictors and challenges.Perioperative management of the bleeding patient.
P2860
Q30831817-27A4FD7C-288A-49DF-A9AA-806B5A1EFACDQ33430766-6919C93A-8197-4281-829D-A1DB0E9CA181Q33677370-D5E0A518-8E7E-446F-A584-32029E11E16AQ34005911-A6B75EF0-6F7F-4F4B-ADE3-DA81807AA1BFQ34143840-024D711B-7A2A-424B-9B14-109133FA10F4Q34157871-1107D5CC-C915-4854-B39F-C07DAE6B631DQ35106780-4C41B052-A350-451B-8231-1A4AD99B727DQ35807333-FD647B93-4EAA-4F60-9B79-AA15AC1EA256Q36969992-75E186C3-F2DA-4976-8AB0-676233B97439Q37239381-AE238254-0838-4AA8-9217-C09FD5277B5AQ37278551-FF5FDB3E-15A9-4105-9910-B81EC40BE418Q39044272-D6625650-AF3A-41D5-A5BB-FECED7DFAC88Q42393855-086342A9-5344-44D4-96C5-66066557FAD2Q45865634-DA28E6A6-79B9-4919-A9A4-2F261715F9C5Q47132745-9D9BA61D-95A3-4D9F-B278-20528FC600DFQ50312912-EA710494-F8ED-44F3-8A8E-809E243DB5E7
P2860
Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@en
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@nl
type
label
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@en
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@nl
prefLabel
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@en
Intraoperative use of low-dose ...... ng thoracic aortic operations.
@nl
P2093
P2860
P1476
Intraoperative use of low-dose ...... ing thoracic aortic operations
@en
P2093
Evelyn L Lockhart
G Chad Hughes
Jeffrey G Gaca
Judson B Williams
Mayur B Patel
Nicholas D Andersen
Syamal D Bhattacharya
P2860
P304
1921-8; discussion 1928-9
P356
10.1016/J.ATHORACSUR.2012.02.037
P407
P577
2012-05-01T00:00:00Z